Advertisement
BY vs CARE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BY is a Hold and CARE is a Buy.
Momentum Indicator for BY turns positive, indicating new upward trend
BY saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In 57 of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at 68%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BY's RSI Oscillator exited the oversold zone, 16 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for BY just turned positive on October 16, 2026. Looking at past instances where BY's MACD turned positive, the stock continued to rise in 26 of 40 cases over the following month. The odds of a continued upward trend are 65%.
BY moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where BY advanced for three days, in 156 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
BY broke above its upper Bollinger Band on October 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BY entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 19 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. BY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.330) is normal, around the industry mean (1.269). P/E Ratio (11.532) is within average values for comparable stocks, (13.317). Projected Growth (PEG Ratio) (0.160) is also within normal values, averaging (1.190). Dividend Yield (0.015) settles around the average of (0.035) among similar stocks. P/S Ratio (3.712) is also within normal values, averaging (3.738).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Momentum Indicator for CARE turns positive, indicating new upward trend
CARE saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 72 similar instances where the indicator turned positive. In 53 of the 72 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CARE just turned positive on October 02, 2026. Looking at past instances where CARE's MACD turned positive, the stock continued to rise in 26 of 37 cases over the following month. The odds of a continued upward trend are 70%.
Following a +1.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where CARE advanced for three days, in 211 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
CARE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CARE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The Aroon Indicator for CARE entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.
The Tickeron SMR rating for this company is 23 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CARE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.313) is normal, around the industry mean (1.271). P/E Ratio (5.271) is within average values for comparable stocks, (13.247). Projected Growth (PEG Ratio) (0.130) is also within normal values, averaging (1.190). Dividend Yield (0.013) settles around the average of (0.035) among similar stocks. P/S Ratio (3.140) is also within normal values, averaging (3.738).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
BY | CARE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 27 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 57 Fair valued | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 34 | 20 | |
SMR RATING 1..100 | 19 | 23 | |
PRICE GROWTH RATING 1..100 | 43 | 41 | |
P/E GROWTH RATING 1..100 | 26 | 93 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CARE's Valuation (47) in the Regional Banks industry is in the same range as BY (57). This means that CARE’s stock grew similarly to BY’s over the last 12 months.
CARE's Profit vs Risk Rating (20) in the Regional Banks industry is in the same range as BY (34). This means that CARE’s stock grew similarly to BY’s over the last 12 months.
BY's SMR Rating (19) in the Regional Banks industry is in the same range as CARE (23). This means that BY’s stock grew similarly to CARE’s over the last 12 months.
CARE's Price Growth Rating (41) in the Regional Banks industry is in the same range as BY (43). This means that CARE’s stock grew similarly to BY’s over the last 12 months.
BY's P/E Growth Rating (26) in the Regional Banks industry is significantly better than the same rating for CARE (93). This means that BY’s stock grew significantly faster than CARE’s over the last 12 months.
| BY | CARE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 59% | N/A |
| Stochastic ODDS (%) | 2 days ago 45% | 2 days ago 42% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 74% |
| MACD ODDS (%) | 2 days ago 65% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 57% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 52% | 2 days ago 71% |
| Advances ODDS (%) | 2 days ago 56% | 3 days ago 65% |
| Declines ODDS (%) | 11 days ago 57% | 6 days ago 61% |
| BollingerBands ODDS (%) | 2 days ago 59% | 2 days ago 61% |
| Aroon ODDS (%) | 2 days ago 47% | 2 days ago 54% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BY’s FA Score shows that 2 FA rating(s) are green while CARE’s FA Score has 2 green FA rating(s).
- BY’s FA Score: 2 green, 3 red.
- CARE’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BY’s TA Score shows that 5 TA indicator(s) are bullish while CARE’s TA Score has 4 bullish TA indicator(s).
- BY’s TA Score: 5 bullish, 4 bearish.
- CARE’s TA Score: 4 bullish, 3 bearish.
Price Growth
BY (@Regional Banks) experienced а +3.00% price change this week, while CARE (@Regional Banks) price change was +1.19% for the same time period.
The average weekly price growth across all stocks in the @Regional Banks industry was +2.29%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was +9.12%.
Reported Earning Dates
BY is expected to report earnings on Jan 28, 2027.
CARE is expected to report earnings on Jan 28, 2027.
Industries' Descriptions
@Regional Banks (+2.29% weekly)Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
Advertisement
BY and
Correlation & Price change
A.I.dvisor indicates that over the last year, BY has been closely correlated with HBNC. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if BY jumps, then HBNC could also see price increases.